Rchr
J-GLOBAL ID:201401063465233613   Update date: Oct. 24, 2024

Kanai Masashi

カナイ マサシ | Kanai Masashi
Affiliation and department:
Research field  (1): Tumor diagnostics and therapeutics
Research theme for competitive and other funds  (6):
  • 2017 - 2020 Development of precision medicine for patients with pancreatic cancer who harbor homologous recombinant repair genes
  • 2014 - 2017 Research for heart protection during cancer chemotherapy via regulating cardiac autophagy
  • 2012 - 2015 Investigation of a novel anti-cancer effects of curcumin using comprehensive miRNA expression analysis
  • 2009 - 2010 Pharmacogenetic study to predicting clinical response of oxaliplatin in patients with advanced colorectal cancer
  • 2007 - 2008 Pharmacogenetic analysis of clinical response to oxaliplatin-based Chemotherapy in colorectal cancer patients
Show all
Papers (192):
  • Saki Shimada, Takahiro Yamada, Akari Minamoto, Manami Matsukawa, Ichiro Yabe, Hiroshi Tada, Katsutoshi Oda, Arisa Ueki, Satomi Higashigawa, Maki Morikawa, et al. Nationwide survey of the secondary findings in cancer genomic profiling: survey including liquid biopsy. Journal of human genetics. 2024
  • Tomohiro Kondo, Osamu Kikuchi, Yoshihiro Yamamoto, Tomohiko Sunami, Yafeng Wang, Keita Fukuyama, Tomoki Saito, Hideto Nakahara, Sachiko Minamiguchi, Masashi Kanai, et al. Colorectal cancer harboring EGFR kinase domain duplication response to EGFR tyrosine kinase inhibitors. The oncologist. 2024
  • Shogo Yamamura, Masashi Kanai, Yasuhide Takeuchi, Natsuko Okita, Tomohiro Kondo, Masahiro Yoshioka, Junichi Matsubara, Shigemi Matsumoto, Manabu Muto. Response to capmatinib in a patient with neuroendocrine carcinoma of the gallbladder origin harboring MET amplification. International cancer conference journal. 2024. 13. 2. 83-87
  • Akira Ueta, Atsushi Yamada, Masahiro Yoshioka, Masashi Kanai, Manabu Muto, Natsuko Okita. Remarkable response to capmatinib in a patient with intrahepatic cholangiocarcinoma harboring TFG-MET fusion. International Cancer Conference Journal. 2024. 13. 3. 199-203
  • Kentaro Iwaki, Tomoaki Yoh, Hiroto Nishino, Takahiro Nishio, Yukinori Koyama, Satoshi Ogiso, Takamichi Ishii, Masashi Kanai, Etsuro Hatano. Completion of adjuvant S-1 chemotherapy after surgical resection for biliary tract cancer: A single center experience. Asian journal of surgery. 2023
more...
MISC (127):
  • 住永圭一郎, 吉田博徳, 名取大輔, 島佑介, 味水瞳, 野溝岳, 小笹裕晃, 阪森優一, 阪森優一, 吉岡正博, et al. 当院における胸部悪性腫瘍に対するComprehensive Genomic Profilingの有用性の検証. 日本肺癌学会学術集会号. 2023. 64th (CD-ROM)
  • 近藤知大, 金井雅史, 山本佳宏, 福山啓太, 山田敦, 吉岡正博, 松原淳一, 松本繁己, 小杉眞司, 武藤学. 包括的がんゲノムプロファイリングにおける二次的所見疑いバリアントの絞り込み基準. 日本内科学会雑誌. 2022. 111
  • Tomohiro Kondo, Takahiro Yamada, Masahiro Yoshioka, Masakazu Nishigaki, Yoshihiro Yamamoto, Tadayuki Kou, Junichi Matsubara, Masashi Kanai, Shigemi Matsumoto, Manabu Muto, et al. Confirmatory germline testing for presumed germline pathogenic variants using tumor-only testing. JOURNAL OF CLINICAL ONCOLOGY. 2021. 39. 15
  • 小杉眞司, 小杉眞司, 小杉眞司, 平沢晃, 平沢晃, 矢部一郎, 矢部一郎, 多田寛, 多田寛, 桑田健, et al. OncoGuide NCCオンコパネルシステムの改定に伴う二次的所見開示推奨度に関するアンケート調査. 日本人類遺伝学会大会プログラム・抄録集. 2021. 66th (CD-ROM)
  • Tomohiro Kondo, Quy Pham Nguyen, Junichi Matsubara, Keita Fukuyama, Motoo Nomura, Taro Funakoshi, Mari Funakoshi, Hitomi Sakamoto, Kanami Ashida, Kumi Mukai, et al. Comprehensive genomic profiling for chemotherapy-naive advanced gastrointestinal malignancies. JOURNAL OF CLINICAL ONCOLOGY. 2020. 38. 4
more...
Books (14):
  • ファーマコゲノミクス解析による治療体系
    日本臨床 2014
  • 抗がん剤のファーマコゲノミクス
    血液内科 2014
  • GEM-1併用療法による切除不能胆道癌の治療成績
    肝胆膵 2012
  • 膵がん領域におけるmiRNA研究
    遺伝子医学Mook 2012
  • 乳癌の薬物療法(主にアバスチン)と血圧管理
    CancerBoard 乳癌 2012
more...
Lectures and oral presentations  (10):
  • Therapeutic application of highly bioavailable curcumin for patients with cancer
    (The second International Conference on Pharma and Food, Shizuoka 2014)
  • The current gideline of pancreatic cancer in Japan
    (Shanghai International Conference on Pancreatic Cancer 2014)
  • がん薬物療法における個別化医療の展望 招待講演
    (京都桂消化器懇話会 2014)
  • がん治療におけるクルクミンの可能性 招待講演
    (第9回 日本食品免疫学会 東京 2013)
  • より安全で確実な効果を目指した胆膵悪性腫瘍に対する化学療法
    (秋田肝胆膵癌研究会 2011)
more...
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page